Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

Over-Allotment Option

29 Jun 2007 17:23

Ferrexpo PLC29 June 2007 The information contained herein is restricted and is not for release,distribution, or publication directly or indirectly, in or into the UnitedStates, Australia, Canada or Japan or to residents or citizens of Australia,Canada or Japan.-------------------------------------------------------------------------------- 29 June 2007 Ferrexpo plc ("Ferrexpo" or the "Company") Announcement of Exercise of Over-Allotment Option Ferrexpo plc announces that, in connection with its initial public offering ofordinary shares, (the "Global Offer"), JPMorgan Cazenove Limited, as stabilisingmanager and on behalf of the underwriters of the Global Offer, has today givennotice to exercise in full the over-allotment option in respect of 10,646,855existing ordinary shares at the offer price of 140 pence per ordinary share. Following the exercise of the over-allotment option, 170,641,893 ordinary shareswill be held in public hands, representing a free float of approximately 28 percent. of the issued share capital of the Company. For further information, please contact: Ferrexpo plc Tel: +44 207 389 8300 Dennis McShane JPMorgan Cazenove Limited Tel: +44 207 588 2828 Ian Hannam and Neil Haycock Deutsche Bank AG, London Branch Tel: +44 207 545 8000 Nicholas Taylor and John Lydon Finsbury Tel: +44 207 251 3801 Robin Walker and Alex Simmons This announcement has been prepared and issued by Ferrexpo plc and is the soleresponsibility of Ferrexpo plc. This announcement may not be distributed, directly or indirectly, in or into theUnited States, Canada, Australia or Japan. This announcement does not constituteor form part of an offer to sell or issue, or any solicitation of an offer tobuy or subscribe for, any securities referred to herein. The Global Offer andthe distribution of this announcement and other information in connection withthe Global Offer in certain jurisdictions may be restricted by law and personsinto whose possession any document or other information referred to herein comesshould inform themselves about and observe any such restriction. Any failure tocomply with these restrictions may constitute a violation of the securities lawsof any such jurisdiction. The securities mentioned herein have not been, and will not be, registered underthe U.S. Securities Act of 1933 (the 'Securities Act'), and may not be offeredor sold in the United States (as such term is defined in Regulation S under theSecurities Act) unless they are registered under the Securities Act or pursuantto an exemption from registration. No public offer of the ordinary shares isbeing made in the United States. JPMorgan Cazenove Limited is acting exclusively for Ferrexpo plc and no one elsein relation to the Global Offer and will not be responsible to any other personfor providing the protections afforded to their respective clients or forproviding advice in relation to the Global Offer. End This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th May 20267:00 amRNSNotice of 2026 Annual General Meeting
28th Apr 20267:00 amRNSFunding Update and Delay in Financial Statements
22nd Apr 20267:00 amRNSUpdate on funding options
20th Apr 20267:00 amRNSSale of Iron Destiny and Update on Funding Options
15th Apr 20267:00 amRNSProduction Report for 1Q 2026
1st Apr 20269:41 amRNSTrading Update
9th Mar 20267:00 amRNSOperations and Corporate Update
2nd Mar 20268:20 amRNSDirector/PDMR Shareholding
24th Feb 20263:35 pmRNSUpdate regarding Ukrainian subsidiary
20th Jan 20263:39 pmRNSUpdate on operations in Ukraine
14th Jan 20267:00 amRNSProduction Report for 4Q 2025
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
14th Nov 20257:05 amRNSDirector Declaration
10th Nov 20257:00 amRNSLimited attack on power infrastructure
4th Nov 20257:00 amRNSPublication of Responsible Business Report
6th Oct 20257:00 amRNSProduction Report for 3Q 2025
11th Sep 202511:59 amRNSGeneral Meeting voting results
11th Aug 20257:00 amRNSPublication of Notice of General Meeting 2025
6th Aug 20257:00 amRNSInterim Results for six months ended 30 June 2025
7th Jul 20257:00 amRNSProduction Report for 2Q 2025
10th Jun 20254:48 pmRNSDirector/PDMR Shareholding
9th Jun 20254:35 pmRNSDirector/PDMR Shareholding
22nd May 202512:47 pmRNSResult of AGM
16th May 20255:00 pmRNSReport on Payments to Governments
15th May 202512:15 pmRNSUpdate regarding Ukrainian subsidiary
30th Apr 20257:00 amRNSLetter to shareholders re: auditor engagement
17th Apr 20255:32 pmRNSUkraine subsidiaries VAT refunds
10th Apr 20257:00 amRNSNotice of Annual General Meeting and 2024 ARA
7th Apr 20257:00 amRNSProduction Report for 1Q 2025
21st Mar 20257:00 amRNSStatement regarding Ukraine VAT refunds
19th Mar 20258:00 amRNSInternational Investment Agreements Notification
19th Mar 20257:00 amRNSFull Year Financial Results for 2024
11th Mar 20257:00 amRNSAnnouncement of Full Year 2024 Financial Results
5th Mar 20257:00 amRNSResponse to SBI Statement
4th Feb 20253:17 pmRNSUpdate regarding Ukrainian subsidiary
23rd Jan 20259:52 amRNSUpdate regarding Ukrainian Subsidiary
16th Jan 202511:30 amRNSUpdate regarding Ukrainian subsidiary
13th Jan 20257:00 amRNSResignation of Non-Executive Director
9th Jan 20257:00 amRNSProduction Report for 4Q 2024
30th Dec 20245:00 pmRNSPublication of Responsible Business Report
30th Dec 20245:00 pmRNSPublication of Climate Change Report
7th Oct 20247:00 amRNSProduction Report for 3Q 2024
19th Sep 202412:31 pmRNSGeneral Meeting voting results
12th Aug 20247:00 amRNSNotice of General Meeting 2024
5th Aug 20244:50 pmRNSUpdate on restrictions on shares in subsidiary
31st Jul 202412:28 pmRNSInterim Results for six months ended 30 June 2024
31st Jul 20247:00 amRNSInterim Results for six months ended 30 June 2024
30th Jul 20245:50 pmRNSInterim Results Advisory
8th Jul 20247:00 amRNSProduction Report for 2Q 2024 and 1H 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.